Patent Assignment
Reel/Frame 058575/0921
Second Amended and Restated Patent Security Agreement
Recorded: 2021-12-22
Pages: 38
Assignor
GLOBAL BLOOD THERAPEUTICS, INC.
Executed: 2021-12-22
Assignee
BIOPHARMA CREDIT PLC
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD, EXETER EX4 4EP, UNITED KINGDOM
Covered Properties
(48)
Compounds and Uses Thereof for the Modulation of Hemoglobin
Substituted Benzaldehyde Compounds and Methods for Their Use in Increasing Tissue Oxygenation
Application:
17/334,213 →
Publication:
US 2021/0290619
Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde
Dosing Regimens for 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde
Application:
17/326,045 →
Publication:
US 2021/0267956
Process for Synthesizing 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)-Pyridin-3-Yl)Methoxy)Benzaldehyde
Application:
17/337,895 →
Publication:
US 2021/0284623
Tablets Comprising 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde
Application:
17/153,232 →
Publication:
US 2021/0283061
Compounds and Uses Thereof for the Modulation of Hemoglobin
Modulators of Hemoglobin
Process for Preparation of 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde
Application:
63/237,780 →
Process for Preparation of 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde
Application:
17/520,453 →
Publication:
US 2022/0144800
Solid Forms of a Modulator of Hemoglobin
Application:
63/188,833 →
Methods of Making a Modulator of Hemoglobin
Application:
63/188,735 →
Methods of Administering Voxelotor
Application:
63/276,498 →
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Substituted Benzaldehyde Compounds and Methods for Their Use in Increasing Tissue Oxygenation
Substituted Benzaldehyde Compounds and Methods for Their Use in Increasing Tissue Oxygenation
Substituted Benzaldehyde Compounds and Methods for Their Use in Increasing Tissue Oxygenation
Substituted Heteroaryl Aldehyde Compounds and Methods for Their Use in Increasing Tissue Oxygenation
Substituted Heteroaryl Aldehyde Compounds and Methods for Their Use in Increasing Tissue Oxygenation
Substituted Heteroaryl Aldehyde Compounds and Methods for Their Use in Increasing Tissue Oxygenation
Substituted Aldehyde Compounds and Methods for Their Use in Increasing Tissue Oxygenation
Compounds and uses thereof for the modulation of hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Bicyclic Heteroaryl Compounds and Uses Thereof for the Modulation of Hemoglobin
1:1 Adducts of Sickle Hemoglobin
Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde
Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde
Methods of Treatment
Methods of Treatment
Dosing Regimens for 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde
Process for Synthesizing 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)-Pyridin-3-Yl)Methoxy)Benzaldehyde
Process for Synthesizing 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)-Pyridin-3-Yl)Methoxy)Benzaldehyde
Tablets Comprising 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Modulators of Hemoglobin
Modulators of Hemoglobin
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 3, 2013
From: TANDEM SCIENCES, INC.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 030145/0085 →
Assignment of Assignor's Interest
Apr 3, 2013
From: CHUANG, CHIHYUAN; MORGAN, BRADLEY; WARRINGTON, JEFFREY
To: CYTOKINETICS, INC.
Reel/Frame 030144/0369 →
Assignment of Assignor's Interest
Apr 3, 2013
From: JACOBSON, MATTHEW P.; HUA, LAN
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 030144/0746 →
Assignment of Assignor's Interest
Apr 3, 2013
From: PAULVANNAN, KUMAR
To: TANDEM SCIENCES, INC.
Reel/Frame 030144/0959 →
Assignment of Assignor's Interest
Apr 3, 2013
From: METCALF, BRIAN
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 030143/0593 →
Assignment of Assignor's Interest
Apr 23, 2013
From: PAULVANNAN, KUMAR
To: TANDEM SCIENCES, INC.
Reel/Frame 030265/0472 →
Assignment of Assignor's Interest
Apr 23, 2013
From: JACOBSON, MATTHEW P.; HUA, LAN
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 030265/0311 →
Assignment of Assignor's Interest
Apr 23, 2013
From: TANDEM SCIENCES, INC.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 030265/0571 →
Assignment of Assignor's Interest
Apr 23, 2013
From: METCALF, BRIAN
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 030264/0851 →
Assignment of Assignor's Interest
Apr 23, 2013
From: CHUANG, CHIHYUAN; MORGAN, BRADLEY; WARRINGTON, JEFFREY
To: CYTOKINETICS, INC.
Reel/Frame 030265/0049 →
Assignment of Assignor's Interest
Mar 27, 2015
From: CYTOKINETICS, INC.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 035272/0422 →
Assignment of Assignor's Interest
Dec 1, 2015
From: METCALF, BRIAN W.; LI, ZHE; XU, QING; GWALTNEY, STEPHEN L., II
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 037182/0007 →
Assignment of Assignor's Interest
Apr 28, 2017
From: CYTOKINETICS, INC.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 042183/0009 →
Assignment of Assignor's Interest
Apr 28, 2017
From: CHUANG, CHIHYUAN
To: CYTOKINETICS, INC.
Reel/Frame 042182/0887 →
Corrective Assignment to Correct the Property Number 14/776,603 Number Should Be 15445878 Previously Recorded at Reel: 042182 Frame: 0887. Assignor(S) Hereby Confirms the Assignment.
May 19, 2017
From: CHUANG, CHIHYUAN
To: CYTOKINETICS, INC.
Reel/Frame 042503/0085 →
Corrective Assignment to Correct the Property Number of 14/776,603 Previously Recorded on Reel 042183 Frame 0009. Assignor(S) Hereby Confirms the Assignment.
May 19, 2017
From: CYTOKINETICS, INC.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 042503/0238 →
Assignment of Assignor's Interest
Jul 31, 2017
From: METCALF, BRIAN W.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 043143/0307 →
Assignment of Assignor's Interest
Jan 11, 2018
From: METCALF, BRIAN
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 044603/0447 →
Assignment of Assignor's Interest
Mar 15, 2018
From: CHUANG, CHIHYUAN
To: CYTOKINETICS, INC.
Reel/Frame 045238/0111 →
Assignment of Assignor's Interest
Mar 15, 2018
From: CYTOKINETICS, INC.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 045238/0138 →
Confirmatory Assignment
May 1, 2018
From: CYTOKINETICS, INC.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 046050/0266 →
Confirmatory Assignment
Aug 31, 2018
From: CYTOKINETICS, INC.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 046992/0680 →
Assignment of Assignor's Interest
Aug 31, 2018
From: METCALF, BRIAN
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 046999/0620 →
Assignment of Assignor's Interest
Aug 31, 2018
From: CYTOKINETICS, INC.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 047005/0028 →
Assignment of Assignor's Interest
Aug 31, 2018
From: CHUANG, CHIHYUAN
To: CYTOKINETICS, INC.
Reel/Frame 047589/0157 →